Case W. McNamara

7.0k total citations
48 papers, 2.0k citations indexed

About

Case W. McNamara is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Parasitology. According to data from OpenAlex, Case W. McNamara has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 17 papers in Infectious Diseases and 13 papers in Parasitology. Recurrent topics in Case W. McNamara's work include Parasitic Infections and Diagnostics (12 papers), Malaria Research and Control (12 papers) and Computational Drug Discovery Methods (8 papers). Case W. McNamara is often cited by papers focused on Parasitic Infections and Diagnostics (12 papers), Malaria Research and Control (12 papers) and Computational Drug Discovery Methods (8 papers). Case W. McNamara collaborates with scholars based in United States, Switzerland and China. Case W. McNamara's co-authors include Elizabeth A. Winzeler, Arnab K. Chatterjee, Peter G. Schultz, Melissa S. Love, Partho Ghosh, Annelies S. Zinkernagel, David Plouffe, Victor Nizet, Thierry T. Diagana and Bryan K. S. Yeung and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Case W. McNamara

46 papers receiving 2.0k citations

Peers

Countries citing papers authored by Case W. McNamara

Since Specialization

Citations

This map shows the geographic impact of Case W. McNamara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Case W. McNamara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Case W. McNamara more than expected).

Fields of papers citing papers by Case W. McNamara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Case W. McNamara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Case W. McNamara. The network helps show where Case W. McNamara may publish in the future.

Co-authorship network of co-authors of Case W. McNamara

This figure shows the co-authorship network connecting the top 25 collaborators of Case W. McNamara. A scholar is included among the top collaborators of Case W. McNamara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Case W. McNamara. Case W. McNamara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-Throughput Repurposing Screen Reveals Compounds with Activity against Toxoplasma gondii Bradyzoites 2025 ·ACS Infectious Diseases ·Taher Uddin, Jing Xia, Yong Fu, Case W. McNamara, Arnab K. Chatterjee, L. David Sibley	1
2	Novel isoxazole thiophene-containing compounds active against Mycobacterium tuberculosis 2025 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), J. C. Webb, Case W. McNamara, Arnab K. Chatterjee, Baiyuan Yang	1
3	Synthesis and Structure-Activity Relationship of Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease with Antiviral Potency 2024 ·Bioorganic & Medicinal Chemistry Letters ·C. Rouch, Arnab K. Chatterjee, (unknown), (unknown), Alan Chu, (unknown), (unknown), Laura Riva, Case W. McNamara, Karen C. Wolff, (unknown), Anna De Falco, G.T. Montelione, (unknown)	0
4	Cryptosporidium life cycle small molecule probing implicates translational repression and an Apetala 2 transcription factor in macrogamont differentiation 2024 ·PLoS Pathogens ·(unknown), (unknown), (unknown), Rajiv S. Jumani, Erin E. Stebbins, (unknown), (unknown), Melissa S. Love, Case W. McNamara, Christopher D. Huston	2
5	Safe drugs with high potential to block malaria transmission revealed by a spleen-mimetic screening 2023 ·Nature Communications ·(unknown), (unknown), Joel Tärning, (unknown), Aurélie Fricot, (unknown), (unknown), Pablo Gamallo, (unknown), Pascal Amireault, Michaël Dussiot, Ming Dao, Mitchell Hull, Case W. McNamara, Camille Roussel, Papa Alioune Ndour, Laura M. Sanz, Francisco‐Javier Gamo, Pierre Buffet	7
6	Drug Discovery for Cutaneous Leishmaniasis: A Review of Developments in the Past 15 Years 2023 ·Microorganisms ·(unknown), Case W. McNamara, Malina A. Bakowski	7
7	Synthesis and structure–activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents 2023 ·Bioorganic & Medicinal Chemistry Letters ·Baiyuan Yang, (unknown), (unknown), Gencheng Li, Grant A. L. Bare, Alessandro Cascioferro, Melissa S. Love, H. Michael Petrassi, K. Barry Sharpless, Case W. McNamara, Arnab K. Chatterjee	3
8	Modular, stereocontrolled C _β –H/C _α –C activation of alkyl carboxylic acids 2019 ·Proceedings of the National Academy of Sciences ·Ming Shang, Karla Santos Feu, Julien C. Vantourout, Lisa M. Barton, Heather L. Osswald, Nobutaka Kato, Kerstin Gagaring, Case W. McNamara, Gang Chen, Liang Hu, Shengyang Ni, (unknown), Miao Chen, Rohan R. Merchant, Tian Qin, Stuart L. Schreiber, Bruno Melillo, Jin‐Quan Yu, Phil S. Baran	42
9	A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors 2019 ·Nature Communications ·Rajiv S. Jumani, (unknown), Erin E. Stebbins, (unknown), Peter G. Miller, (unknown), Kovi Bessoff, (unknown), Melissa S. Love, Case W. McNamara, Christopher D. Huston	29
10	Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis 2019 ·Nature Communications ·Christopher S. Lunde, Erin E. Stebbins, Rajiv S. Jumani, Mahmudul Hasan, Peter G. Miller, John Barlow, Yvonne R. Freund, Pamela Berry, Rianna Stefanakis, Jiří Gut, Philip J. Rosenthal, Melissa S. Love, Case W. McNamara, Eric E. Easom, Jacob J. Plattner, Robert T. Jacobs, Christopher D. Huston	44
11	Cell-based screen for discovering lipopolysaccharide biogenesis inhibitors 2018 ·Proceedings of the National Academy of Sciences ·Ge Zhang, Vadim Baidin, Karanbir S. Pahil, (unknown), David Tomasek, Nitya S. Ramadoss, Arnab K. Chatterjee, Case W. McNamara, Travis S. Young, Peter G. Schultz, Timothy C. Meredith, Daniel Kahne	69
12	A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box 2018 ·Antimicrobial Agents and Chemotherapy ·Rajiv S. Jumani, Kovi Bessoff, Melissa S. Love, Peter G. Miller, Erin E. Stebbins, (unknown), Mary Ann Campbell, Marvin J. Meyers, Jennifer A. Zambriski, (unknown), Ashley K. Woods, Case W. McNamara, Christopher D. Huston	44
13	The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis 2018 ·Proceedings of the National Academy of Sciences ·Jeff Janes, (unknown), Emily Chen, Nicole H. Rogers, Sebastian Burgstaller-Muehlbacher, Laura D. Hughes, Melissa S. Love, Mitchell Hull, Kelli Kuhen, Ashley K. Woods, Sean B. Joseph, H. Michael Petrassi, Case W. McNamara, Matthew S. Tremblay, Andrew I. Su, Peter G. Schultz, Arnab K. Chatterjee	125
14	The Deconstructed Granuloma: A Complex High-Throughput Drug Screening Platform for the Discovery of Host-Directed Therapeutics Against Tuberculosis 2018 ·Frontiers in Cellular and Infection Microbiology ·Lu Huang, Nicole L. Kushner, (unknown), Davide Pisu, Shumin Tan, Case W. McNamara, (unknown), David G. Russell, Amanda C. Brown	19
15	Identification of pathogen genomic variants through an integrated pipeline 2014 ·BMC Bioinformatics ·Micah J. Manary, (unknown), Erika L. Flannery, Selina Bopp, Victoria Corey, (unknown), Case W. McNamara, John R. Walker, Elizabeth A. Winzeler	29
16	Targeting the ERAD pathway via inhibition of signal peptide peptidase for antiparasitic therapeutic design 2012 ·Proceedings of the National Academy of Sciences ·Michael B. Harbut, Bhumit A. Patel, Bryan K. S. Yeung, Case W. McNamara, A. Taylor Bright, (unknown), František Supek, Todd E. Golde, Elizabeth A. Winzeler, Thierry T. Diagana, Doron C. Greenbaum	76
17	A Chemical Genomic Analysis of Decoquinate, a Plasmodium falciparum Cytochrome b Inhibitor 2011 ·ACS Chemical Biology ·Tae‐gyu Nam, Case W. McNamara, Selina Bopp, Neekesh V. Dharia, Stephan Meister, Ghislain M. C. Bonamy, David Plouffe, Nobutaka Kato, (unknown), Badry Bursulaya, Hangjun Ke, Akhil B. Vaidya, Peter G. Schultz, Elizabeth A. Winzeler	69
18	M1 Protein Allows Group A Streptococcal Survival in Phagocyte Extracellular Traps through Cathelicidin Inhibition 2009 ·Journal of Innate Immunity ·Xavier Lauth, Maren von Köckritz‐Blickwede, Case W. McNamara, (unknown), Annelies S. Zinkernagel, Bernard Beall, Partho Ghosh, Richard L. Gallo, Victor Nizet	144
19	In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen 2008 ·Proceedings of the National Academy of Sciences ·David Plouffe, Achim Brinker, Case W. McNamara, Kerstin Henson, Nobutaka Kato, Kelli Kuhen, A. S. Nagle, Francisco Adrián, Jason Matzen, Paul Anderson, Tae‐gyu Nam, Nathanael S. Gray, Arnab K. Chatterjee, Jeff Janes, S. Frank Yan, (unknown), Jeremy S. Caldwell, Peter G. Schultz, Yingyao Zhou, Elizabeth A. Winzeler	325
20	Coiled-Coil Irregularities and Instabilities in Group A Streptococcus M1 Are Required for Virulence 2008 ·Science ·Case W. McNamara, Annelies S. Zinkernagel, Pauline Machebœuf, Madeleine W. Cunningham, Victor Nizet, Partho Ghosh	124

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact